Lipocine Inc.
LPCN
$1.98
-$0.07-3.42%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -112.93% | -114,713.10% | -34.99% | 46.90% | 40.12% |
| Total Depreciation and Amortization | 24.48% | 47.93% | 83.28% | 70.64% | 49.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 102.61% | 116.15% | 107.87% | -106.69% | -108.56% |
| Change in Net Operating Assets | 2,380.14% | 74.75% | 156.26% | -133.05% | -106.76% |
| Cash from Operations | -79.50% | -699.21% | -3.92% | -5.68% | -1.22% |
| Capital Expenditure | -- | -- | 88.80% | -879.35% | -879.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -154.51% | 132.28% | 13.10% | 18.32% | 66.52% |
| Cash from Investing | -155.38% | 140.82% | 15.15% | 16.61% | 64.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6,990.54% | 1,271.00% | 3.63% | -87.79% | -48.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 485.71% |
| Cash from Financing | 6,726.36% | 1,271.00% | 6.32% | -87.91% | -45.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 507.79% | -169.73% | 147.98% | -8.91% | 116.19% |